91 results
Page 2 of 5
8-K
EX-10.1
iiigr f28xu6inlc7
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
1kmxi5 t50gdju
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
ub7zwuhtc0
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm